About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Extension of Closing Date of Entitlement Offer

October 10, 2017

Click here to read more

Post navigation

CEO Quarterly Update

Phosphagenics Entitlement Offer Raises Over AUD3M

Related Posts

Phosphagenics Decides to put its BioElixia Cosmetics Brand up for Sale

February 25, 2015

Watch now: how significant is chronic insomnia in Australia?

October 14, 2026October 14, 2026

Phosphagenics Director and Founder Steps Down

July 9, 2015

Recent Posts

Watch now: how significant is chronic insomnia in Australia?
October 14, 2026
Recruitent recommences for phase III insomnia trial
August 31, 2026
Euroz Hartleys | Successful Phase 3 Interim Results
July 8, 2026

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.